Insider · CIK 0002118509

Glavine Paul

Reports to the SEC for 1 company · TORONTO

Transactions

Companies

Filings

CIK

0002118509

Forms 4 and 5

Insider transactions

5 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-30	HELPHelus Pharma Inc.A Award	Director, Chief Growth Officer	AAward	+248K sh	—	—	4,750,191
2026-09-08	HELPHelus Pharma Inc.P Purchase	Director, Chief Growth Officer	PPurchase	+100K sh	$12.47	+$1.25M	4,271,252
2026-09-08	HELPHelus Pharma Inc.P Purchase	Director, Chief Growth Officer	PPurchase	+100K sh	$12.47	+$1.25M	4,271,252
2026-09-03	HELPHelus Pharma Inc.P Purchase	Director, Chief Growth Officer	PPurchase	+100K sh	$11.78	+$1.18M	4,171,252
2026-08-31	HELPHelus Pharma Inc.P Purchase	Director, Chief Growth Officer	PPurchase	+90K sh	$11.59	+$1.04M	4,071,252

C/O HELUS PHARMA INC. 100 KING STREET W., SUITE 5600

TORONTO, M5X 1C9